OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation

OrganOx reported the completion of its acquisition by Terumo Corporation, following satisfaction of regulatory and closing conditions. OrganOx becomes a wholly owned subsidiary, with the combination intended to scale organ perfusion technologies and broaden global patient reach. The companies highlighted opportunities to invest in R&D, evolve the OrganOx metra platform beyond liver transplantation, and expand use of normothermic machine perfusion for organ support. OrganOx CEO Craig Marshall said joining Terumo will accelerate market expansion and operations to meet urgent demand for donor organs. OrganOx, spun out of the University of Oxford, notes its metra device is approved in multiple regions and has supported thousands of transplants.